Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2022-10-28 Board/Management Inform…
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results
Board/Management Information Classification · 95% confidence The document is a notification about the scheduling of a Board of Directors meeting to consider and approve the company's un-audited financial results for the quarter and half year ended 30th September 2022. It also mentions the trading window closure related to this event. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a board meeting and related procedural information, not the actual financial report or earnings release. Therefore, it fits best under Board/Management Information (MANG), as it informs about a board meeting and related corporate governance matters.
2022-10-28 English
General updates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2022. It is addressed to stock exchanges and relates to regulatory compliance rather than financial results or management information. The document is short (1485 characters) and primarily serves as a certification or attestation. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate rather than a full report or announcement of financial results.
2022-10-14 English
Closure of trading window
Regulatory Filings
2022-09-27 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI Listing Obligations and Disclosure Requirements, 2015, regarding the loss of original share certificates and the issuance of duplicate share certificates. It includes details of shareholders, folio numbers, distinctive numbers, and shares involved. The document requests stock exchanges to disseminate this information and restrain trading in the lost share certificates. This is a regulatory announcement related to share certificates and does not contain financial data, management discussion, or report content. It is not a financial report, earnings release, or management report. It is a regulatory filing informing the stock exchanges and public about share certificate status and related actions. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4213 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2022-09-22 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the reaffirmation of the company's credit rating by CARE Ratings Limited. It provides details on the ratings for various bank facilities and debentures, including rating grades and amounts. There is no financial statement, detailed financial analysis, or comprehensive report content. The document is an update on credit rating status, which relates to financing and capital structure information. The document length is short (1755 characters), and it is an announcement rather than a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-09-05 English
Corp Restructuring - others
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Wockhardt Limited to stock exchanges (BSE and NSE) regarding the restructuring of its US business operations. It discusses operational changes such as closing a manufacturing facility, engaging contract manufacturers, and entering into a Consent Decree with the Department of Justice related to US FDA observations. The document includes a disclosure pursuant to SEBI regulations about the restructuring details and its effects. There are no financial statements, earnings data, or detailed financial analysis present. The document is an update on business restructuring and operational changes, not a financial report or earnings release. It fits best under Capital/Financing Update (CAP) as it relates to significant business restructuring impacting operations and cost structure, which is typical for CAP filings. The document length is under 5,000 characters, but it contains substantive information about restructuring, not just an announcement of a report. Therefore, it is not an RPA or RNS. Hence, the classification is CAP with high confidence.
2022-08-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.